Lv4
498 积分 2022-10-17 加入
An RNA–Deaminase Conjugate Selectively Repairs Point Mutations
1个月前
已完结
Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides
1个月前
已完结
Precision RNA base editing with engineered and endogenous effectors
1个月前
已完结
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
1个月前
已完结
Efficient and Safe In Vivo Treatment of Primary Hyperoxaluria Type 1 via LNP-CRISPR/Cas9-mediated glycolate oxidase disruption
1个月前
已完结
Engineering CAR-T therapies for autoimmune disease and beyond
2个月前
已完结
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
2个月前
已完结
Development of Allogeneic Dual-Targeting CD19/BCMA CAR-T Cell Therapeutics Using ALL-in-One Site-Specific Integration Technology for Autoimmune Diseases
2个月前
已关闭
Co-Transduced CD19/BCMA Dual-Targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma
2个月前
已关闭
Development of Allogeneic Dual-Targeting CD19/BCMA CAR-T Cell Therapeutics Using ALL-in-One Site-Specific Integration Technology for Autoimmune Diseases
2个月前
已关闭
皖公网安备34019202002308
